Annual Gross Margin
41.38%
-3.80%-8.41%
30 April 2024
Summary:
Champions Oncology annual gross profit margin is currently 41.38%, with the most recent change of -3.80% (-8.41%) on 30 April 2024. During the last 3 years, it has fallen by -6.36% (-13.32%). CSBR annual gross margin is now -44.82% below its all-time high of 74.99%, reached on 30 April 2003.CSBR Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
49.70%
+1.48%+3.07%
31 July 2024
Summary:
Champions Oncology quarterly gross profit margin is currently 49.70%, with the most recent change of +1.48% (+3.07%) on 31 July 2024. Over the past year, it has increased by +6.88% (+16.07%). CSBR quarterly gross margin is now -37.33% below its all-time high of 79.30%, reached on 31 October 2002.CSBR Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Gross Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.4% | +16.1% |
3 y3 years | -13.3% | -5.2% |
5 y5 years | -12.5% | +1.2% |
CSBR Gross Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -20.2% | at low | -5.2% | +43.2% |
5 y | 5 years | -20.2% | at low | -13.2% | +43.2% |
alltime | all time | -44.8% | +198.1% | -37.3% | +554.7% |
Champions Oncology Gross Margin History
Date | Annual | Quarterly |
---|---|---|
July 2024 | - | 49.70%(+3.1%) |
Apr 2024 | 41.38%(-8.4%) | 48.22%(+39.0%) |
Jan 2024 | - | 34.70%(-19.0%) |
Oct 2023 | - | 42.82%(+10.3%) |
July 2023 | - | 38.83%(-11.5%) |
Apr 2023 | 45.18%(-12.9%) | 43.86%(+10.4%) |
Jan 2023 | - | 39.72%(-17.0%) |
Oct 2022 | - | 47.88%(-1.7%) |
July 2022 | - | 48.69%(-5.8%) |
Apr 2022 | 51.88%(+8.7%) | 51.69%(+0.5%) |
Jan 2022 | - | 51.44%(-1.9%) |
Oct 2021 | - | 52.41%(+0.7%) |
July 2021 | - | 52.05%(+16.5%) |
Apr 2021 | 47.74%(+1.4%) | 44.69%(-21.9%) |
Jan 2021 | - | 57.24%(+29.5%) |
Oct 2020 | - | 44.21%(+0.2%) |
July 2020 | - | 44.10%(+4.1%) |
Apr 2020 | 47.08%(-0.5%) | 42.36%(-18.6%) |
Jan 2020 | - | 52.01%(+5.9%) |
Oct 2019 | - | 49.10%(+10.8%) |
July 2019 | - | 44.31%(+0.1%) |
Apr 2019 | 47.30%(-1.2%) | 44.27%(-5.1%) |
Jan 2019 | - | 46.67%(-3.7%) |
Oct 2018 | - | 48.44%(-4.0%) |
July 2018 | - | 50.47%(+17.9%) |
Apr 2018 | 47.86%(+29.2%) | 42.79%(-16.7%) |
Jan 2018 | - | 51.34%(+4.8%) |
Oct 2017 | - | 49.01%(+3.2%) |
July 2017 | - | 47.51%(+53.8%) |
Apr 2017 | 37.04%(+65.9%) | 30.89%(-5.0%) |
Jan 2017 | - | 32.51%(-35.7%) |
Oct 2016 | - | 50.57%(+61.8%) |
July 2016 | - | 31.25%(+79.1%) |
Apr 2016 | 22.32%(+60.8%) | 17.45%(-0.2%) |
Jan 2016 | - | 17.48%(-45.9%) |
Oct 2015 | - | 32.31%(+66.1%) |
July 2015 | - | 19.45%(-38.4%) |
Apr 2015 | 13.88%(-69.7%) | 31.56%(-495.5%) |
Jan 2015 | - | -7.98%(-192.1%) |
Oct 2014 | - | 8.66%(-12.9%) |
July 2014 | - | 9.94%(-73.4%) |
Apr 2014 | 45.77% | 37.39%(-33.3%) |
Date | Annual | Quarterly |
---|---|---|
Jan 2014 | - | 56.04%(+40.1%) |
Oct 2013 | - | 39.99%(-10.5%) |
July 2013 | - | 44.67%(+189.7%) |
Apr 2013 | 35.98%(+14.3%) | 15.42%(-73.1%) |
Jan 2013 | - | 57.42%(+108.8%) |
Oct 2012 | - | 27.50%(-8.8%) |
July 2012 | - | 30.15%(-375.8%) |
Apr 2012 | 31.47%(-35.7%) | -10.93%(-124.5%) |
Jan 2012 | - | 44.53%(+17.5%) |
Oct 2011 | - | 37.91%(-15.4%) |
July 2011 | - | 44.80%(+7.3%) |
Apr 2011 | 48.98%(-19.5%) | 41.77%(-15.8%) |
Jan 2011 | - | 49.63%(+23.8%) |
Oct 2010 | - | 40.09%(-39.1%) |
July 2010 | - | 65.88%(-7.5%) |
Apr 2010 | 60.86%(+25.3%) | 71.26%(+39.9%) |
Jan 2010 | - | 50.94%(-31.0%) |
Oct 2009 | - | 73.86%(+141.7%) |
July 2009 | - | 30.56%(-36.9%) |
Apr 2009 | 48.57%(-25.3%) | 48.46%(+51.9%) |
Jan 2009 | - | 31.91%(-43.1%) |
Oct 2008 | - | 56.08%(-8.6%) |
July 2008 | - | 61.37%(-11.8%) |
Apr 2008 | 65.00%(-7.0%) | - |
Apr 2004 | 69.92%(-6.8%) | 69.58%(+3.6%) |
Jan 2004 | - | 67.13%(-9.0%) |
Oct 2003 | - | 73.80%(+6.4%) |
July 2003 | - | 69.33%(-5.7%) |
Apr 2003 | 74.99%(+4.1%) | 73.54%(-1.2%) |
Jan 2003 | - | 74.44%(-6.1%) |
Oct 2002 | - | 79.30%(+9.4%) |
July 2002 | - | 72.51%(-0.4%) |
Apr 2002 | 72.03%(+2.0%) | 72.77%(-1.2%) |
Jan 2002 | - | 73.64%(-0.1%) |
Oct 2001 | - | 73.74%(+7.1%) |
July 2001 | - | 68.88%(-3.6%) |
Apr 2001 | 70.61%(+294.7%) | 71.45%(+4.3%) |
Jan 2001 | - | 68.49%(+0.2%) |
Oct 2000 | - | 68.33%(-7.6%) |
July 2000 | - | 73.96%(+377.5%) |
Apr 2000 | 17.89% | 15.49%(-22.6%) |
Jan 2000 | - | 20.00% |
FAQ
- What is Champions Oncology annual gross profit margin?
- What is the all time high annual gross margin for Champions Oncology?
- What is Champions Oncology annual gross margin year-on-year change?
- What is Champions Oncology quarterly gross profit margin?
- What is the all time high quarterly gross margin for Champions Oncology?
- What is Champions Oncology quarterly gross margin year-on-year change?
What is Champions Oncology annual gross profit margin?
The current annual gross margin of CSBR is 41.38%
What is the all time high annual gross margin for Champions Oncology?
Champions Oncology all-time high annual gross profit margin is 74.99%
What is Champions Oncology annual gross margin year-on-year change?
Over the past year, CSBR annual gross profit margin has changed by -3.80% (-8.41%)
What is Champions Oncology quarterly gross profit margin?
The current quarterly gross margin of CSBR is 49.70%
What is the all time high quarterly gross margin for Champions Oncology?
Champions Oncology all-time high quarterly gross profit margin is 79.30%
What is Champions Oncology quarterly gross margin year-on-year change?
Over the past year, CSBR quarterly gross profit margin has changed by +6.88% (+16.07%)